These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice. Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of α-synuclein inhibits mitochondrial Ca Erustes AG; D'Eletto M; Guarache GC; Ureshino RP; Bincoletto C; da Silva Pereira GJ; Piacentini M; Smaili SS J Neurosci Res; 2021 Nov; 99(11):2932-2947. PubMed ID: 34510532 [TBL] [Abstract][Full Text] [Related]
7. Increased Lysosomal Exocytosis Induced by Lysosomal Ca Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622 [TBL] [Abstract][Full Text] [Related]
8. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells. Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K. Choong CJ; Say YH Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409 [TBL] [Abstract][Full Text] [Related]
10. Distinct alpha-Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH-SY5Y cells. Pantazopoulou M; Brembati V; Kanellidi A; Bousset L; Melki R; Stefanis L J Neurochem; 2021 Mar; 156(6):880-896. PubMed ID: 32869336 [TBL] [Abstract][Full Text] [Related]
11. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons. Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146 [TBL] [Abstract][Full Text] [Related]
12. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487 [TBL] [Abstract][Full Text] [Related]
13. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats. Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101 [TBL] [Abstract][Full Text] [Related]
14. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease. Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177 [TBL] [Abstract][Full Text] [Related]
15. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease. Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034 [TBL] [Abstract][Full Text] [Related]
16. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction. Bellomo G; Paciotti S; Gatticchi L; Parnetti L Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779 [TBL] [Abstract][Full Text] [Related]
17. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756 [TBL] [Abstract][Full Text] [Related]
18. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease. McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553 [TBL] [Abstract][Full Text] [Related]
19. TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells. Wang MX; Cheng XY; Jin M; Cao YL; Yang YP; Wang JD; Li Q; Wang F; Hu LF; Liu CF Exp Neurol; 2015 Sep; 271():112-21. PubMed ID: 26001614 [TBL] [Abstract][Full Text] [Related]
20. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein. Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]